Pure Global AI
AMAR · structured requirements

🇮🇱 Israel medical device regulatory data

Explore the medical device requirements currently available for Israel, organized by topic and linked to official sources.

47 facts21 dimensions12 official sourceslatest verification 2026-09-15

Advertising, claims & promotion

Which claims, audiences, channels, approvals, and restrictions apply?

Compare countries

Device-advertising restrictions under the Medical Equipment Law

advertising.registration-conditions-and-public-health-restrictions
Fact-level verified

The Medical Equipment Law defines advertising directed to the public (excluding scientific literature), permits the registration of medical equipment to be made subject to conditions restricting the manner or content of its advertising, and authorizes the Director to restrict advertising whose manner or content harms or may harm public health. Except in an urgent public-health case, the affected party must be given an opportunity to present arguments before a restriction is imposed.

Conditions
  • These are case-specific registration and enforcement powers, not a blanket pre-approval requirement for every device advertisement.
  • Scientific literature is excluded from the law's definition of public advertising.

Independently corrected against the official Knesset law text; violating a restriction imposed under section 12 is an offence under section 15(a)(3).

Approval validity & renewal

What expires, what is retained periodically, and when must renewal start?

Compare countries

Registration validity periods

authorization.duration
Fact-level verified

Correction with concrete values: a device is registered in the AMAR register for a period not exceeding five years; implants are registered for up to two years; devices registered or permitted for marketing in a recognized state are registered until the expiry of that state's registration/permit, provided the Israeli registration period does not exceed 5 years from the Israeli registration date.

Conditions
  • Implants: up to 2 years.
  • Recognized-state devices: track that state's validity, capped at 5 years.

Corrects the baseline route-dependent description to concrete durations.

Renewal window and temporary registration

authorization.renewal
Fact-level verified

The renewal application must be filed during the 4 months before registration expiry (earlier filing is possible with valid regulatory approvals per the renewal procedure). If a current CE certificate is not yet available at filing, a temporary register registration is set with validity of 6 additional months from the previous registration's expiry. Under the law (sec. 8), a timely-filed application deems the registration extended until the Director-General's decision.

Conditions
  • Earlier-than-4-months filing requires valid regulatory approvals.
  • 6-month temporary registration applies where CE certificate is missing at renewal.

Deemed-extension rule per law sec. 8(c) in the official law text held from gov.il. Confirms the baseline authorization-renewal fact.

Administrative extension to 30.6.2025

renewal.admin-extension-2025
Fact-level verified

Administrative extension ended 31.12.2024 covering certificates expiring 1.12.2022-30.12.2024 (due to EU extensions): where a renewal application was filed in Caspit with a submission date before 28.2.2025, the register registration is extended until 30.6.2025 unless cancelled or refused. Excludes Class I devices that must be registered in the declaration track; applies to register certificates only, not import approvals; not applicable where a change procedure applies. Fast-track renewals received an updated certificate within 10 working days.

Conditions
  • Renewal filed in Caspit with submission date before 28.2.2025.
  • Class I declaration-track devices excluded.
  • Import approvals excluded.

· Effective until 2025-06-30

Authority & regime

Which authority and binding regime govern this product, task, and date?

Compare countries

Competent authority

authority.competent-authority
Fact-level verified

The Medical Device Division — AMAR (אגף ציוד רפואי - אמ"ר) of the Israel Ministry of Health — is the competent authority. It registers medical devices in Israel, issues various types of import permits, monitors marketing, issues export-supporting documents, and operates a registration, supervision and control mechanism over manufacture, import and marketing of medical devices.

Conditions
  • Applies to all medical equipment and laboratory equipment (IVD).

AMAR sits under the ministry's Medical Technologies, Information and Research directorate per division letterheads.

Change control

Does the event require internal documentation, notice, prior approval, transfer, or a new application?

Compare countries

Change classification taxonomy

change.available-outcomes
Fact-level verified

Changes to a registered device are classified by the manufacturer as 'material' (מהותי), 'non-material' (לא מהותי) or 'administrative' (אדמיניסטרטיבי); it is the registration holder's responsibility to verify the nature and classification of each change with the manufacturer and file the change application accordingly. Combination rules: several material changes, or material combined with non-material/administrative, are filed as one 'material' application; non-material combined with administrative is filed as 'non-material' (one row for the highest-ranked change). An EU-reclassification increase in risk class requires a 'material' change application. Categories marked '^V' in the change procedure may be filed through the fast 'non-material' channel despite being manufacturer-classified material.

Conditions
  • Manufacturer classifies; holder verifies and files accordingly.
  • ^V-marked categories get the relief channel.

Confirms the baseline change-outcomes fact (prior approval/amendment vs new application) with the official taxonomy.

Clinical investigation & performance

Which clinical or IVD performance evidence or study is required and accepted?

Compare countries

Clinical-evaluation sample imports

clin.evaluation-import-condition
Fact-level verified

A one-time import approval for clinical-evaluation samples is available only if a registration application for the product has already been filed in the register; the import application must state explicitly that the purpose is clinical evaluation. Without a filed registration application, no further one-time approval is given.

Conditions
  • Registration application must already be filed.
  • Purpose must be stated explicitly on the import application.

Registration-stage clinical evidence for Class IIb/III is the risk analysis and clinical trials summary filed with the reference authority (see dossier facts).

Device definition & scope

Is the product a device, IVD, accessory, software, or borderline product locally?

Compare countries

IVD scope

scope.ivd-equal-rules
Fact-level verified

Laboratory equipment (IVD, ציוד מעבדתי) is regulated by AMAR under the same rules as medical equipment at the corresponding risk classes (Europe defines 4 risk classes for medical and laboratory equipment; FDA defines 3).

Conditions
  • Class mapping follows the corresponding reference-market class.

Dossier requirements

Which evidence, local deltas, formats, and signatures are required?

Compare countries

Combinations that cannot share one application

dossier.combination-prohibited
Fact-level verified

A single application must not combine: a drug-device combination product with a device that does not contain a drug; implants with non-implants; a product of animal/biological origin with a product that is not of that origin; ionizing-radiation-emitting equipment with non-ionizing equipment; or a device intended for a professional user with a device intended for a lay user.

REG-2024/03 corpus anchor sec-6.

Finished products only

dossier.finished-products-only
Fact-level verified

AMAR approval is for finished products only. The application consists of an electronic form (site 'forms' category) plus scanned attachments; separate applications are required per device family/class, and separately for implants, biological products, radiation-emitting devices and different user types.

Splitting rules per the same guidelines.

Class IIb/III evidence

dossier.high-risk-evidence
Fact-level verified

For Class IIb (or FDA Class II) or Class III products, the application must include the risk-analysis summary as filed with the approving authority and a summary of the clinical trials file. A local manufacturer without recognized-state approvals (Class IIb/III) must additionally attach a risk analysis, a clinical trials file and an opinion from a senior medical figure holding an Israeli practice licence.

Conditions
  • Class IIb/III (or FDA Class II/III).
  • Local-manufacturer route only for the senior medical opinion.

What one registration application may include

dossier.one-application-options
Fact-level verified

Each registration application may include only one of: a single product; a family of products, provided every product has the same risk class; a system whose parts are used together; or a procedure pack of products from the same manufacturer. Models included in the application must be listed on the registration form.

REG-2024/03 corpus anchor sec-6.

Accepted reference approvals

dossier.reference-approvals
Fact-level verified

Accepted reference approvals: US FDA; Europe CE plus Declaration of Conformity (Class 1 self-declaration accepted, except sterile/measuring devices which need notified-body CE and a split application); Australia-NZ TGA of the REGISTRATION type only; Health Canada. An application filed with an expired approval is rejected on the spot; all approval dates must be entered DD/MM/YYYY.

Conditions
  • TGA limited to REGISTRATION type.
  • Sterile/measuring Class 1 devices require NB-issued CE.

Economic-operator roles

Which manufacturer, representative, holder, applicant, importer, and distributor roles apply?

Compare countries

Israeli registration holder/importer as applicant

market-entry.local-role
Fact-level verified

Applications are filed by the Israeli registration holder/importer: the dossier includes current importer and manufacturer declarations (importer/manufacturer declaration no older than 1 month; foreign-manufacturer declaration no older than 3 months; personal wet signatures + company stamp + signer's role) and the local business licence number and expiry per regulation 1.3 issued by the local authority.

Conditions
  • Declarations must be on ministry wording; deviations are not accepted.

Confirms the baseline licensed-importer-as-applicant archetype.

Change of registration holder

market-entry.representative-change
Fact-level verified

On change of the registration holder/importer, the new registration holder's declaration replaces the old importer declaration; in the fast track a lawyer-signed affidavit of the appropriate wording must be filed.

Conditions
  • Whether a fresh registration is needed depends on product changes (route dependent).

Confirms the baseline representative-change fact.

Establishment, import & distribution

Which establishment licences, importer permissions, and distribution controls apply?

Compare countries

AMAR import approvals

import.approval-types
Fact-level verified

AMAR issues one-time import approvals (e.g. for use in a private clinic or for evaluation) and periodic (annual) import approvals; importing for marketing requires the product to be registered in the Medical Equipment Register. Currently no fee is required to obtain import approvals; import questions go to Amar.Importation@moh.health.gov.il.

Conditions
  • One-time approvals serve non-marketing purposes; marketing import requires registration.

Lab-use bio-material import pilot (Maslul)

import.bio-material-pilot
Fact-level verified

From 8.2.2023, applications to import biological-source materials intended for laboratory use only (not for use in humans) are approved on the basis of an importer declaration: a full application in the Maslul (מסלו"ל) system plus a signed importer declaration per the attached guide.

Conditions
  • Laboratory use only; not for human use.
  • Importer declaration per published guide.

Effective from 2023-02-08

Label, IFU & language

Which label and IFU elements, languages, symbols, and translation controls apply?

Compare countries

Home-use labelling languages

label.home-use-hebrew-arabic
Fact-level verified

For devices intended also for the home (non-professional) user, the application must include the leaflet, a scanned packaging sample and user instructions in Hebrew and Arabic, compared against the approved (English) source approved by the foreign authorities; additional languages are permitted; translation must be done by external translation companies with a certification document from them.

Conditions
  • Home-use (non-professional) devices.

Manufacturer PMS

Which PMS plan, report, PMCF or PMPF, trend, and lifecycle-update duties apply?

Compare countries

Class I post-market surveillance report

pms.class1-pmsr
Fact-level verified

For Class I medical devices a Post-Market Surveillance Report (PMSR) is required, detailing the monitoring and audit activities performed to improve the device's safety and quality and to correct deficiencies found. The ministry's supervision page further requires monitoring and audit activities to evaluate registered devices and improve their safety and quality, with reporting to AMAR.

Conditions
  • Class I devices (PMSR).

Supervision-duty wording per the AMAR supervision page (gov.il/he/pages/amr-supervision).

Official forms & portals

Which current form, portal, account, and submission package must be used?

Compare countries

Caspit portal for registrations/renewals

forms.caspit-portal-renewals
Fact-level verified

Registration applications to AMAR are submitted through the ministry's Caspit (כספות) portal (launched 25.1.2017, replacing email-only submission); the 1.12.2024 extension announcement confirms renewal applications are filed in the Caspit system and an 'application submission confirmation' with a submission date is issued.

Caspit launch date per the AMAR announcements page.

Caspit electronic dossier format

forms.caspit-zip-250mb
Fact-level verified

A register-registration application must be filed electronically as an electronic registration form (PDF, version 9.0 recommended) plus a compressed zip of the required accompanying documents not larger than 250MB, and must be sent through the ministry Caspit (כספות) portal only.

Conditions
  • The procedure uses 'ציוד רפואי' to include laboratory equipment (IVD).

REG-2024/03 corpus anchor sec-6. Distinct from the 2014 email/15MB mechanics and from the Caspit renewal-filing announcement.

Email submission mechanics

forms.email-submission
Fact-level verified

Applications are an electronic form plus scanned attachments sent by email to amar@moh.health.gov.il; email size must not exceed 15MB (larger submissions are split into several emails, up to about 40 files). If no acknowledgment is received within 7 days (excluding concentrated government holiday periods), the application must be resent; during that period the applicant receives an intake confirmation with a reference number and device number, or a rejection notice.

Current holder declaration is a Word file

forms.holder-declaration-word
Fact-level verified

Annex 1 of REG-2024/03 is the new-applicant declaration for medical devices and IVDs on the regular registration track. The current Word (word) declaration file for download and completion is published on the ministry website; the PDF annex itself is the pointer, not a fillable form.

Conditions
  • Regular registration track; new registration applicant.

REG-2024/03 corpus anchor annex-1.

QMS, audit & inspection

Which QMS, audit, inspection, and certificate scope is accepted or required?

Compare countries

QMS evidence requirement

qms.iso13485-or-gmp
Fact-level verified

ISO 13485 certificates are required for every manufacturer in the product's supply chain; alternatively, valid GMP certificates may be attached. ISO 5001 certificates are required for other participants in the supply chain (e.g. subcontractors/suppliers). The official Q&A clarifies ISO 13485 is submitted for the manufacturer and/or the manufacturing sites of the device.

Conditions
  • Applies to all supply-chain manufacturers; GMP accepted as alternative.

Confirms the baseline QMS rule.

Recall, FSCA & market surveillance

Which recall, FSCA, notice, and authority-coordination duties apply?

Compare countries

Recall notices publication

recall.public-notices
Fact-level verified

AMAR publishes a list of recall notices (קריאות להחזרה) for medical devices on its site; the law empowers the Director-General to order marketing restrictions and recalls of registered devices (Chapter C of the law, in the official text held).

Recall-order powers per the law text held from gov.il (sec. 12).

Registration pathways

Which registration, notification, listing, reliance, or conformity route applies?

Compare countries

Self-declaration registration track

pathways.declaration-track
Fact-level verified

Declaration track (מסלול רישום בהצהרה), launched 3.9.2023: self-declaration by the registration holder and/or importer for low-risk (Class I incl. Is/Im/Ir) devices and low-risk IVDs that are registered and marketed in recognized states only; the register registration certificate is sent immediately after the application is accepted in the registration system, and no later than 48 hours. It is the first stage of the 'Enabling Regulation' (רגולציה מאפשרת) programme.

Conditions
  • Class I (incl. Is/Im/Ir) devices and low-risk IVDs only.
  • Device must already be registered and marketed in a recognized state.
  • Applications not submitted per the procedure are rejected with an automatic reply within 4 hours.

Effective from 2023-09-03

Launch date and programme framing per the AMAR announcements page; certificate timing ('יישלח באופן מיידי... ולא יאוחר מ-48 שעות') per REG-2023/04.

Fast registration track with two channels

pathways.fast-track
Fact-level verified

Fast track (מסלול רישום מהיר), launched 2.6.2024 as the second stage of the 'Enabling Regulation', with two channels: fast 1 (ערוץ מהיר 1) — Class II with FDA approval (510(k)/De Novo), EU Class IIa with a recognized-state approval, or IVD Self Test (IVDD)/class B (IVDR), all requiring 4 months of marketing; new registrations handled within up to 45 working days and renewals within up to 10 working days. Fast 2 (ערוץ מהיר 2) — EU Class IIb or IVD LIST B (IVDD)/class C (IVDR) relying on registrations from two independent regulatory authorities (e.g. EU and FDA) with 6 months of marketing; new registrations and renewals handled within up to 60 working days. Change applications in the fast track are also open to Class III and high-risk IVDs (non-substantial changes up to 10 working days; the substantial-change option does not exist for Class III). Requires a lawyer-affirmed affidavit (תצהיר מאומת ע"י עו"ד); the channel is chosen by the highest classification in the application file.

Conditions
  • Fast 1: Class II with FDA approval marketed 4 of the last months in the US; EU Class IIa or IVD class B/Self Test marketed 4 months in a recognized state.
  • Fast 2: EU Class IIb or IVD LIST B/class C with approvals from two independent regulatory authorities and 6 months of marketing (with an FDA approval, actual US marketing is not required).
  • Multi-class systems: channel set by the highest-class product in the file.
  • Applications missing the fast-track code are examined in the regular track.

Effective from 2024-06-02

Launch date and affidavit requirement per the AMAR announcements and Q&A pages; channel clocks, scope extensions (Class III and high-risk IVD change applications) and marketing-history conditions per REG-2024/06 tables.

Regular registration track

pathways.regular-track
Fact-level verified

Regular track (מסלול רגיל): the standard route for new, renewal and change applications, with a published handling target of 120 days. Track choice is by product risk class; Israeli-manufacturer devices registered and marketed in a recognized state may also use the fast track.

Conditions
  • Applies where the device is not eligible for the declaration or fast tracks (e.g. no recognized-state registration).

Confirms and enriches the baseline market-access-route fact.

Reliance & recognition

Which foreign decisions or evidence can be reused, with what effect and conditions?

Compare countries

Existing records include acceptance, restrictions and evidence reuse. The applicable product scope and conditions are preserved below; a reference does not by itself confer market access.

Israel approvals and evidence in other markets (0 records)

No linked record is currently maintained. This does not establish that a pathway is unavailable.

Prior approvals and evidence for Israel (14 records)

IsraelUS FDA

Prior approval / evidence record

FDA 510(k)/De Novo/PMA

Authority

FDA 510(k)/De Novo/PMA

Accepted

Yes

Benefit

Israel does not run an independent assessment: a recognized-state approval is what makes a device registrable at all, and which one you hold decides which track you land in. A US clearance plus four months of US marketing puts a Class II device on fast track 1, and a US clearance paired with an approval from a second independent authority puts an EU Class IIb device on fast track 2 without needing actual marketing in the US.

Timeline Savings

Fast track 1 is up to 45 working days and fast track 2 up to 60, against the 120-day regular-track target

Maintained reference · planning ranges remain estimates · reviewed 2026-08-30

IsraelNMPA

Regulatory reference

China NMPA approval: not an accepted regulatory approval in AMAR procedure REG-2024/03

reliance.china-nmpa-no-recognition-route-amar-procedure
Pending verification
Statement

The cited AMAR procedure requests regulatory evidence from recognised states for its recognised-state pathway. This does not establish that a China-made device is legally barred from the ordinary assessment route without FDA/CE approval. Confirm the current ordinary-route procedure and product scope before concluding whether NMPA-only evidence is eligible.

Source Jurisdiction Id

china

Source Authority Id

nmpa

Source Approval

China NMPA medical device registration certificate (Class II/III) or Class I filing record

Target Jurisdiction Id

israel

China Classes In Scope

NMPA Class II/III certificates and Class I filings; AMAR regular track for imported devices of all risk classes

Edge Type

Eligibility Unresolved

Market Access Strength

undetermined

Regulatory Layer

Product Marketing

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Recognised-state evidence and ordinary assessment are separate questions.
  • Current route eligibility remains subject to independent primary-source verification.
  • Independent verification is incomplete. Treat this record as a research lead, not a confirmed benefit or exclusion; see the 2026-09-15 independent review.

Effective from 2025-01-01

Source passage: אישורים רגולטורים (אישורים ממדינות מוכרות (עפ"י חוק הציוד הרפואי) ... FDA אישורים רגולטוריים של ה-FDA (למשל 510K, PMA, CTFG, Reg. & Listing) ... CE אישורים רגולטוריים ממדינות מוכרות באירופה ... DOC הצהרת תאימות לדרישות ... אישורים רגולטוריים ממדינות מוכרות אחרות (למשל: קנדה, אוסטרליה, וכו') || Q&A: עבור מוצר שאיננו רשום ומשווק במדינה מוכרת יש להגיש בקשה לרישום במסלול הרישום הרגיל.

IsraelUS FDA · UK MHRA · Germany · France · Italy · Spain · Netherlands · Belgium · Ireland · Denmark · Sweden · Finland · Norway · Iceland · Greece · Portugal · Austria · Swissmedic · Australia TGA · Health Canada · New Zealand

Regulatory reference

Recognized-state registration route

reliance.recognized-country-route
Fact-level verified

A device registered, or approved for marketing and actually marketed, in a 'recognized state' (מדינה מוכרת) is registered in the Israeli register for a period not exceeding the period it may be marketed in that state, capped at 5 years from Israeli registration. Recognized states are listed in the First Addendum to the law — 21 states including the US, UK, Germany, France, Italy, Spain, the Netherlands, Belgium, Ireland, Denmark, Sweden, Finland, Norway, Iceland, Greece, Portugal, Austria, Switzerland, Australia, Canada and New Zealand (no single 'EU' entry: member states are listed individually).

Conditions
  • Device must be registered or permitted for marketing and actually marketed in the recognized state.

First Addendum list per the official Sefer HaChukim text of the law held from gov.il.

IsraelUS FDA · Australia TGA · Health Canada · EU conformity assessment

Regulatory reference

Health Canada evidence

reliance.health-canada-evidence
Fact-level verified

Health Canada medical device licences are among the accepted reference approvals for AMAR registration (listed in the official registration guidelines alongside FDA, CE and TGA); Canadian registrations in principle have no expiry, so a validity of 5 years from the submission date is entered in the approvals table when filing.

Conditions
  • No-expiry approvals are assigned 5-year validity from submission.

Health Canada listed as accepted approval per the AMAR registration guidelines PDF.

IsraelEU conformity assessment

Regulatory reference

MDDR CE from notified bodies in non-recognized states (pilot)

reliance.nb-nonrecognized-pilot
Fact-level verified

Pilot: for register registration, MDR CE certificates issued by notified bodies from non-recognized states (accredited by the EU under MDR) are recognized; the pilot has been extended until 31.12.2026, after which ministry policy will be examined in light of its results.

Conditions
  • Pilot only; notified body must be EU-accredited under MDR.
  • Extended to 31.12.2026.

· Effective until 2026-12-31

IsraelEU conformity assessment

Regulatory reference

EU CE with extended validity

reliance.ce-extended-validity
Fact-level verified

Where registration relies on European approvals extended under EU transition rules, the Israeli register validity is based on the extension granted under the European regulation; the expiry date entered in the application (per new EU rules, e.g. 31.12.2027 or 31.12.2028) must follow those conditions.

Conditions
  • Applies to CE-based registrations with EU-granted extensions.

Confirms the baseline EU-CE reliance edge.

IsraelAustralia TGA · Health Canada

Prior approval / evidence record

Health Canada or Australia TGA

Authority

Health Canada or Australia TGA

Accepted

Yes

Benefit

REG-2024/06 restricts the regulatory certificate types that can be entered on an application to CE, FDA, FDA K510, Australian Ministry of Health and Canadian Ministry of Health, so a Canadian or Australian approval is a first-class reference certificate on the same terms as a US or EU one.

Timeline Savings

Same track placement as the US and EU certificates above

Maintained reference · planning ranges remain estimates · reviewed 2026-08-30

IsraelNMPA

Regulatory reference

China NMPA approval: China is not a recognized state under the Medical Equipment Law First Addendum

reliance.china-nmpa-not-reference
Pending verification
Statement

Israel's Medical Equipment Law 5772-2012 defines a 'recognized state' (מדינה מוכרת) as any state listed in the First Addendum, and section 6(b) grants the abridged recognized-state registration only to devices registered or marketed in such a state. The First Addendum enumerates 21 states exhaustively and China is not among them, so an NMPA registration certificate does not qualify a device for the recognized-state route.

Source Jurisdiction Id

china

Source Authority Id

nmpa

Source Approval

China NMPA medical device registration certificate (Class II/III) or Class I filing record

Target Jurisdiction Id

israel

China Classes In Scope

All NMPA classes (Class I filing, Class II/III registration); relevant to all Israeli risk classes and tracks

Edge Type

No Reliance Route

Market Access Strength

none

Regulatory Layer

Product Marketing

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Recognized-state route (s. 6(b)) requires the device to be registered in, or permitted for marketing in and actually marketed in, one of the 21 listed states
  • The Minister may amend the First Addendum only by order with Knesset committee approval (s. 19); no amendment adding China has been published
  • Independent verification is incomplete. Treat this record as a research lead, not a confirmed benefit or exclusion; see the 2026-09-15 independent review.

Effective from 2013-09-10

Source passage: "מדינה מוכרת" — כל אחת מהמדינות המנויות בתוספת הראשונה ... תוספת ראשונה (סעיף 1, ההגדרה "מדינה מוכרת") רשימת המדינות המוכרות: 1. אוסטריה; 2. אוסטרליה; 3. איטליה; 4. איסלנד; 5. אירלנד; 6. ארצות הברית; 7. בלגיה; 8. בריטניה; 9. גרמניה; 10. דנמרק; 11. הולנד; 12. יוון; 13. נורווגיה; 14. ניו–זילנד; 15. ספרד; 16. פורטוגל; 17. פינלנד; 18. צרפת; 19. קנדה; 20. שבדיה; 21. שוויץ.

IsraelAustralia TGA

Regulatory reference

Australia TGA and Health Canada evidence

reliance.au-ca-no-expiry-5y
Fact-level verified

Australian and Canadian registrations in principle have no expiry; when filing (fast track), a validity of 5 years from the submission date is entered in the approvals table. TGA approvals are accepted only of the REGISTRATION type (not ARTG listing types other than registration).

Conditions
  • TGA evidence limited to REGISTRATION type.
  • No-expiry approvals are assigned 5-year validity from submission.

TGA REGISTRATION-only condition per the AMAR registration guidelines PDF.

IsraelUS FDA · EU conformity assessment

Regulatory reference

US FDA evidence and classification precedence

reliance.us-fda-precedence
Fact-level verified

US FDA marketing authorizations (e.g. 510(k)) are primary reference evidence; like other no-expiry approvals, 510(k) clearances are assigned 5-year validity from the submission date in the approvals table. Where EU and US classifications differ, the FDA classification takes precedence, provided the product meets the conditions of the chosen track.

Conditions
  • FDA precedence applies when EU/US classifications differ.

Confirms the baseline US-FDA reliance edge.

IsraelMDSAP

Prior approval / evidence record

MDSAP

Authority

MDSAP

Accepted

No

Benefit

Not a recognized certificate type under REG-2024/06 and not a route into any track.

Timeline Savings

None

Maintained reference · planning ranges remain estimates · reviewed 2026-08-30

IsraelNMPA

Prior approval / evidence record

NMPA-Israel MoH joint declaration of intent (2020): no recognition effect

reliance.china-nmpa-bilateral-programme
Pending verification
Statement

On 8 December 2020 NMPA Commissioner Jiao Hong and Israel's Ambassador to China (on behalf of the Israeli Minister of Health) signed a Joint Declaration of Intent on cooperation in the regulation of drugs, medical devices and cosmetics between NMPA and the Israeli Ministry of Health. The instrument is a cooperation-intent declaration only; it contains no mutual recognition or reliance on NMPA registrations, and Israel's recognized-state list was not amended as a result.

Source Jurisdiction Id

china

Source Authority Id

nmpa

Source Approval

China NMPA medical device registration certificate (Class II/III) or Class I filing record

Target Jurisdiction Id

israel

China Classes In Scope

Drugs, medical devices and cosmetics (regulatory cooperation; no product-class scope)

Edge Type

Cooperation Mou

Market Access Strength

none

Regulatory Layer

Product Marketing

Local Application Required

Yes

Target Decision Retained

Yes

Conditions
  • Cooperation instrument only (exchange and cooperation in regulation); no registration effect in Israel
  • Signed under the 2017 China-Israel 'innovative comprehensive partnership' framework
  • Independent verification is incomplete. Treat this record as a research lead, not a confirmed benefit or exclusion; see the 2026-09-15 independent review.

Effective from 2020-12-08

Source passage: 2020年12月8日上午,国家药监局局长焦红与以色列驻华大使何泽伟在京签署了《中华人民共和国国家药品监督管理局与以色列国卫生部关于药品、医疗器械和化妆品监管领域合作意向联合声明》(以下简称《联合声明》),旨在进一步促进双方药品、医疗器械和化妆品监管交流与合作。

IsraelSource authority not specified

Prior approval / evidence record

Second independent regulatory authority (fast track 2)

Authority

Second independent regulatory authority (fast track 2)

Accepted

Yes

Benefit

AMAR defines an independent authority as a recognized authority whose own registration does not itself rest on a registration in another recognized state, and puts the burden on the registration holder to check with the manufacturer how each foreign registration was actually granted. Two approvals from the same underlying assessment do not qualify.

Timeline Savings

Opens fast track 2 at up to 60 working days for EU Class IIb and IVD LIST B / class C

Maintained reference · planning ranges remain estimates · reviewed 2026-08-30

IsraelEU conformity assessment

Prior approval / evidence record

EU CE Mark

Authority

EU CE Mark

Accepted

Yes

Benefit

A recognized-state CE certificate puts a Class I device on the declaration track and an EU Class IIa device or IVDD Self Test / IVDR class B on fast track 1, in both cases with four months of marketing in the recognized state. EU Class IIb and IVDD LIST B / IVDR class C need the CE certificate plus a second independent authority for fast track 2.

Timeline Savings

Declaration track is up to 48 hours and fast track 1 up to 45 working days, against the 120-day regular-track target

Maintained reference · planning ranges remain estimates · reviewed 2026-08-30

Special access & derogation

Is an emergency, compassionate, custom, humanitarian, or other exceptional path available?

Compare countries

Personal import route

special.personal-import
Fact-level verified

A private individual or physician fills their ID-number details instead of importer details on the import application; attaches a prescription or physician guidance letter for purchasing the device; and attaches a declaration that the import is for personal use only. No regulatory approvals need be attached.

Conditions
  • Personal use only.
  • Physician letter/prescription required.

Second Addendum exemptions

special.second-addendum-exemptions
Fact-level verified

Devices listed in the Second Addendum to the Medical Equipment Law are exempt from registration: medical equipment may be manufactured and marketed only if registered (and per registration conditions) or if listed in the Second Addendum.

Conditions
  • Exempt categories are enumerated in the law's Second Addendum.

Submission communications & appeal

How are deficiencies answered, clocks handled, and decisions escalated or appealed?

Compare countries

Transfer between tracks

comm.track-transfer
Fact-level verified

An application may be transferred from the regular track to the fast track via a cover letter requesting the transfer, a signed affidavit and an updated marketing-data document. Document requirements are identical across tracks; the difference is the required declaration document (fast track requires a lawyer-affirmed affidavit). If no intake confirmation arrives within 7 days, the application must be resent.

7-day acknowledgment rule per the registration guidelines.

UDI, listing & traceability

Which UDI, device listing, database, and traceability duties apply?

Compare countries

Vigilance & incident reporting

What is reportable, by whom, where, in what format, and by what deadline?

Compare countries

Registration-holder duty to report special events

vigilance.holder-reportable-events
Fact-level verified

The registration holder must perform monitoring and audit actions to evaluate registered devices and improve their safety and quality, report their performance to AMAR, and report every special event connected to the use of a registered device that comes to their knowledge, in three categories: (1) a severe malfunction of the device that occurred in Israel or another country and could endanger a patient's health; (2) use of the device that caused, or is suspected of having caused, harm to a patient's physical or mental health that is not expected in the normal course of the disease or treatment, or use that caused significant harm or a patient's death in Israel or another country; (3) an action taken by a health authority worldwide or a notice published by a manufacturer, registration holder or health authority regarding the device, its marketing and use, or new information published in the main scientific literature regarding the device's safety.

Conditions
  • Applies to every holder of a registration certificate in the Medical Devices Register (medical equipment incl. IVDs).
  • Foreign events are equally reportable: the categories explicitly cover occurrences and actions outside Israel.

The cited supervision page states the duty and the three categories but does not state a reporting deadline. A malfunction-report form for local manufacturers/importers is linked from the same page.

AMAR vigilance reporting channel

vigilance.reporting-channel
Fact-level verified

Reports of monitoring actions and special events are submitted to the Medical Device Division (AMAR) of the Ministry of Health by email to amar.pms@moh.health.gov.il; a dedicated malfunction-report form for accessories and medical instrumentation exists for local manufacturers and importers.

Conditions
  • Email is the published submission channel for registration-holder vigilance reports.

The form link on the page targets the forms collector 'טופס דיווח תקלות באביזרים ומכשור רפואי: יצרן מקומי / יבואן'.

Related structured datasets

Classification systems · 1 record
Open Reference-market classes I, IIa, IIb and III (EU) or I, II, III (FDA) →
Id

israel:medical-device

Jurisdiction Id

israel

Domains
  • medical-device
  • ivd
Name

Reference-market classes I, IIa, IIb and III (EU) or I, II, III (FDA)

Description

Israel has no domestic classification rulebook: devices are keyed to the classification of their reference market. Europe distinguishes four classes and the US FDA three, and where the two conflict the FDA classification prevails (AMAR Q&A). Track eligibility and dossier depth follow these classes in AMAR procedures REG-2023/04, REG-2024/03 and REG-2024/06.

Classes
  • Id

    i

    Label

    Class I

    Normalized Risk Level

    low

  • Id

    iia

    Label

    Class IIa

    Normalized Risk Level

    medium

  • Id

    iib

    Label

    Class IIb

    Normalized Risk Level

    high

  • Id

    iii

    Label

    Class III

    Normalized Risk Level

    highest

Regulator

Ministry of Health Medical Device Division (AMAR)

Official Domains
  • gov.il
Source Status

official-source-verified

Source Title

שאלות ותשובות בנושא רישום ציוד רפואי — AMAR Q&A, classification of medical equipment (updated 24.8.2026)

Source Url

https://www.gov.il/he/pages/amr-q-a

Verified On

2026-08-28

Source Supports
  • class-axis
  • ivd-class-axis
Notes
  • AMAR Q&A: Europe distinguishes 4 classes (I, IIa, IIb, III) and the US FDA 3 (I, II, III); where the EU and FDA classifications of a device differ, the FDA classification prevails.
  • REG-2024/03 Annex 6b keys the technical-file requirements to the class columns 'IIb, III (EU) / III (FDA)' and 'IIa (EU) / II (FDA)'; the declaration track (REG-2023/04) covers Class I incl. Is/Im/Ir and low-risk IVDs registered and marketed in a recognized state.
  • IVDs are registered in the same register under the Medical Equipment Law with parallel EU classes: the fast-track channels map Self Test/List B (IVDD) or class B/C (IVDR) to fast 1/fast 2 (REG-2024/06).
Registration pathways, prior approvals and planning · 1 record
Open Israel registration →
Country

Israel

Jurisdiction Id

israel

Country Code

IL

Flag

🇮🇱

Regulator

Ministry of Health - Medical Devices Division

Regulator Abbrev

AMAR

Region

middle-east

Tier

2

Risk Classification

Reference-market classes: EU I, IIa, IIb, III; US FDA I, II, III (FDA prevails on conflict)

Classes
  • Id

    declaration-track

    Class Name

    Declaration track — Class I (incl. Is/Im/Ir) and low-risk IVDs

    Pathway

    Declaration based on prior registration in a recognized state

    Official Timeline
    Min

    1

    Max

    2

    Unit

    days

    Verification Status

    official-verified

    Official Source
    Title

    AMAR REG-2023/04 — declaration-route registration (certificate within 48 hours)

    Url

    https://www.gov.il/BlobFolder/dynamiccollectorresultitem/guidelines-for-registering-medical-equipment-declaration-route/he/units_amar_guidelines-for-registering-medical-equipment-declaration-route.pdf

    Effective Date

    2023-09-03

    Accessed Date

    2026-08-28

    Realistic Timeline
    Min

    1

    Max

    2

    Unit

    days

    Notes
    • REG-2023/04: the registration certificate is sent immediately after the application is accepted in the registration system, and no later than 48 hours; non-conforming submissions receive an automatic rejection reply within 4 hours.
    • Eligibility: Class I (incl. Is/Im/Ir) devices and low-risk IVDs already registered and marketed in a recognized state.
    Clinical Trial Required

    No

    Local Testing Required

    No

    Gmp Required

    No

  • Id

    fast-track-1

    Class Name

    Fast track 1 — Class II (FDA approval), EU Class IIa, IVD Self Test/class B

    Pathway

    Fast registration, channel 1 (one reference market)

    Official Timeline
    Min

    10

    Max

    45

    Unit

    working-days

    Verification Status

    official-verified

    Official Source
    Title

    AMAR REG-2024/06 — fast-track registration handling times by channel

    Url

    https://www.gov.il/BlobFolder/dynamiccollectorresultitem/fast-track-registration-procedure-medical-equipment-register/he/units_amar_Fast-track-registration-procedure-medical-equipment-register.pdf

    Effective Date

    2024-06-02

    Accessed Date

    2026-08-28

    Realistic Timeline
    Min

    2

    Max

    3

    Unit

    months

    Notes
    • REG-2024/06: new registrations handled within up to 45 working days; renewals within up to 10 working days; substantial changes up to 45 and non-substantial changes up to 10 working days.
    • Eligibility: Class II with an FDA 510(k)/De Novo approval and 4 months of US marketing; EU Class IIa or IVD Self Test (IVDD)/class B (IVDR) with a recognized-state approval and 4 months of marketing. Requires a lawyer-affirmed affidavit; AMAR publishes this clock by track and channel, not by risk class.
    Clinical Trial Required

    No

    Local Testing Required

    No

    Gmp Required

    Yes

  • Id

    fast-track-2

    Class Name

    Fast track 2 — EU Class IIb, IVD LIST B/class C (two independent authorities)

    Pathway

    Fast registration, channel 2 (two independent reference authorities)

    Official Timeline
    Min

    60

    Max

    60

    Unit

    working-days

    Verification Status

    official-verified

    Official Source
    Title

    AMAR REG-2024/06 — fast-track registration handling times by channel

    Url

    https://www.gov.il/BlobFolder/dynamiccollectorresultitem/fast-track-registration-procedure-medical-equipment-register/he/units_amar_Fast-track-registration-procedure-medical-equipment-register.pdf

    Effective Date

    2024-06-02

    Accessed Date

    2026-08-28

    Realistic Timeline
    Min

    3

    Max

    5

    Unit

    months

    Notes
    • REG-2024/06: new registrations and renewals handled within up to 60 working days; substantial changes up to 60 and non-substantial changes up to 10 working days.
    • Eligibility: EU Class IIb or IVD LIST B (IVDD)/class C (IVDR) with approvals from two independent regulatory authorities (e.g. EU and FDA) and 6 months of marketing (with an FDA approval, actual US marketing is not required). Change applications are also open to Class III and high-risk IVDs, but the substantial-change option does not exist for Class III; AMAR publishes this clock by track and channel, not by risk class.
    Clinical Trial Required

    No

    Local Testing Required

    No

    Gmp Required

    Yes

  • Id

    regular-track

    Class Name

    Regular track — all classes (standard route)

    Pathway

    Regular registration (new, renewal and change applications)

    Official Timeline
    Min

    120

    Max

    120

    Unit

    days

    Verification Status

    official-verified

    Official Source
    Title

    AMAR Q&A — registration and import of medical equipment (regular-track handling target of 120 days)

    Url

    https://www.gov.il/he/pages/amr-q-a

    Accessed Date

    2026-08-28

    Realistic Timeline
    Min

    4

    Max

    8

    Unit

    months

    Notes
    • AMAR publishes a handling target of 120 days for regular-track new, renewal and change applications; devices not eligible for the declaration or fast tracks use this route.
    • AMAR publishes this target by track, not by risk class.
    Clinical Trial Required

    No

    Local Testing Required

    No

    Gmp Required

    Yes

Prior Approvals
  • Authority

    FDA 510(k)/De Novo/PMA

    Accepted

    Yes

    Benefit

    Israel does not run an independent assessment: a recognized-state approval is what makes a device registrable at all, and which one you hold decides which track you land in. A US clearance plus four months of US marketing puts a Class II device on fast track 1, and a US clearance paired with an approval from a second independent authority puts an EU Class IIb device on fast track 2 without needing actual marketing in the US.

    Timeline Savings

    Fast track 1 is up to 45 working days and fast track 2 up to 60, against the 120-day regular-track target

  • Authority

    EU CE Mark

    Accepted

    Yes

    Benefit

    A recognized-state CE certificate puts a Class I device on the declaration track and an EU Class IIa device or IVDD Self Test / IVDR class B on fast track 1, in both cases with four months of marketing in the recognized state. EU Class IIb and IVDD LIST B / IVDR class C need the CE certificate plus a second independent authority for fast track 2.

    Timeline Savings

    Declaration track is up to 48 hours and fast track 1 up to 45 working days, against the 120-day regular-track target

  • Authority

    Health Canada or Australia TGA

    Accepted

    Yes

    Benefit

    REG-2024/06 restricts the regulatory certificate types that can be entered on an application to CE, FDA, FDA K510, Australian Ministry of Health and Canadian Ministry of Health, so a Canadian or Australian approval is a first-class reference certificate on the same terms as a US or EU one.

    Timeline Savings

    Same track placement as the US and EU certificates above

  • Authority

    Second independent regulatory authority (fast track 2)

    Accepted

    Yes

    Benefit

    AMAR defines an independent authority as a recognized authority whose own registration does not itself rest on a registration in another recognized state, and puts the burden on the registration holder to check with the manufacturer how each foreign registration was actually granted. Two approvals from the same underlying assessment do not qualify.

    Timeline Savings

    Opens fast track 2 at up to 60 working days for EU Class IIb and IVD LIST B / class C

  • Authority

    MDSAP

    Accepted

    No

    Benefit

    Not a recognized certificate type under REG-2024/06 and not a route into any track.

    Timeline Savings

    None

Key Requirements
  • Israel Authorized Representative (for foreign manufacturers)
  • Hebrew labeling
  • ISO 13485 certification
  • Free Sale Certificate
  • Fast-track applications require an affidavit; declaration-track Class I eligibility requires prior registration in a recognized state
  • Change applications carry their own clocks on both fast tracks: administrative changes up to 10 working days, non-substantial changes up to 10, substantial changes up to 45 on fast track 1 and up to 60 on fast track 2
  • A renewal filed without a current CE certificate is entered in the register temporarily, valid for six months beyond the expiry of the previous registration, so the certificate gap does not take the device off the market
Local Rep Required

Yes

Local Rep Name

Israel Authorized Representative

Mdsap Accepted

No

Mdsap Benefit

Not accepted. AMAR recognises CE, FDA, FDA K510, Australian and Canadian certificates, and ISO 13485 is required separately.

Registration Validity

Not a fixed Israeli term. The registration runs to the expiry of the underlying reference certificate, which the applicant must enter on the application. Where the reference approval carries no expiry, as with an FDA clearance, REG-2024/06 requires an expiry date of five years from the date of submission, which is where the commonly quoted five-year figure comes from.

Verification Status

official-verified

Official Sources
  • Title

    AMAR REG-2023/04 — declaration-route registration (certificate within 48 hours)

    Url

    https://www.gov.il/BlobFolder/dynamiccollectorresultitem/guidelines-for-registering-medical-equipment-declaration-route/he/units_amar_guidelines-for-registering-medical-equipment-declaration-route.pdf

    Effective Date

    2023-09-03

    Accessed Date

    2026-08-28

  • Title

    AMAR REG-2024/06 — fast-track registration handling times by channel

    Url

    https://www.gov.il/BlobFolder/dynamiccollectorresultitem/fast-track-registration-procedure-medical-equipment-register/he/units_amar_Fast-track-registration-procedure-medical-equipment-register.pdf

    Effective Date

    2024-06-02

    Accessed Date

    2026-08-28

  • Title

    AMAR Q&A — registration and import of medical equipment (regular-track handling target of 120 days)

    Url

    https://www.gov.il/he/pages/amr-q-a

    Accessed Date

    2026-08-28

Reviewed On

2026-08-30

Last Updated

2026-08-30

Process
Template Id

default

Status

planning-template

Usage Rule

Maintained planning steps and estimates, not verified regulator deadlines.

Steps
  • Step

    1

    Title

    Pre-Submission Preparation

    Description

    Gather technical documentation, quality management system (QMS) records, and clinical data required by AMAR. Appoint a Israel Authorized Representative.

    Duration

    1-3 months

    Icon

    📋

  • Step

    2

    Title

    Application Submission

    Description

    Submit complete registration dossier to AMAR including device description, risk analysis, and testing reports.

    Duration

    1-2 weeks

    Icon

    📤

  • Step

    3

    Title

    Administrative Review

    Description

    AMAR reviews application for completeness. May request additional documents or clarifications.

    Duration

    2-4 weeks

    Icon

    🔍

  • Step

    4

    Title

    Technical Evaluation

    Description

    In-depth technical assessment of device safety and performance. AMAR may issue questions.

    Duration

    1-2 days

    Icon

    ⚙️

  • Step

    5

    Title

    Registration Approval

    Description

    Upon successful review, AMAR issues Israel market authorization certificate.

    Duration

    1-2 weeks

    Icon

    ✅

Government fee schedules · 1 record
Open Israel fees →
Jurisdiction Id

israel

Country

Israel

Country Code

IL

Authority

AMAR

Low Risk Local
Min

0

Max

0

Currency

ILS

Per Product

Yes

High Risk Local
Min

0

Max

0

Currency

ILS

Per Product

Yes

Details
  • Id

    amar-registration-change-renewal

    Item

    AMAR registration, change, or renewal

    Currency

    ILS

    Amount Local

    0

    Amount Local Formatted

    ILS 0

    Frequency

    Per application

    Notes

    The Ministry page instructs applicants to enter ILS 0 in the payment field.

    Amount Status

    exact-current

    Verification Status

    official-verified

    Source Url

    https://www.gov.il/he/pages/amr-licensing

    Source Title

    Israel Ministry of Health AMAR licensing: registration, change, and renewal fees waived

    Source Effective Date

    2022-08-15

    Verified On

    2026-08-25

Notes
  • The Ministry of Health states that no fee has been collected for registration, change, or renewal in the medical-equipment register since 15 August 2022 (the fee was ILS 1,200 as of December 2013).
  • Import approvals (one-time and periodic/annual) are also currently free; the AMAR Q&A states no fee is required to obtain import approvals.
Last Updated

2026-08-25

Verification Status

official-verified

Official Sources
  • Title

    Israel Ministry of Health AMAR licensing: registration, change, and renewal fees waived

    Url

    https://www.gov.il/he/pages/amr-licensing

    Effective Date

    2022-08-15

    Accessed Date

    2026-08-25

  • Title

    Israel AMAR questions and answers: import approvals carry no fee

    Url

    https://www.gov.il/he/pages/amr-q-a

    Accessed Date

    2026-08-25

Reviewed On

2026-08-25

Amount Status

exact-current

Range Available

Yes

Additional certifications and licences · 1 record
Open Israel certifications →
Slug

israel

Market

Israel

Confidence

low

Schemes
  • Id

    amar-electrical-emc-evidence

    Name

    AMAR electrical/EMC evidence

    Category

    Medical Electrical Safety

    Status

    Included In Medical Registration

    Object

    Finished Device

    Note

    No local conformity-assessment scheme: AMAR registration evidence is foreign reference approvals (US FDA; Europe CE plus Declaration of Conformity; TGA registration; Health Canada) plus ISO 13485 (or valid GMP) certificates for supply-chain manufacturers; applications with an expired approval are rejected on the spot.

    Source Urls
    • https://www.gov.il/BlobFolder/dynamiccollectorresultitem/amr-guidelines_amr_reg_guidelines/he/units_amar_AMR_reg_guidelines.pdf
    Source Binding

    reviewed

  • Id

    ministry-of-communications-wireless-import-type-approval

    Name

    Ministry of Communications wireless import/type approval

    Category

    Radio Spectrum

    Status

    Mandatory If Feature

    Object

    Wireless Equipment

    Source Urls
    • https://www.gov.il/en/service/approval_of_wireless_equipment_imported
    Source Binding

    candidate

  • Id

    sii-mandatory-standards

    Name

    SII mandatory standards

    Category

    General Electrical Components

    Status

    Mandatory If Feature

    Object

    Listed Product Or Component

    Source Binding

    unresolved

Official Sources
  • Authority

    Ministry of Communications

    Topic

    wireless equipment import approval

    Url

    https://www.gov.il/en/service/approval_of_wireless_equipment_imported

  • Authority

    Ministry of Communications

    Topic

    wireless device type approval

    Url

    https://www.gov.il/he/service/request-type-approval-wireless-device-new

  • Authority

    AMAR

    Topic

    registration guidelines foreign approvals and quality certificates

    Url

    https://www.gov.il/BlobFolder/dynamiccollectorresultitem/amr-guidelines_amr_reg_guidelines/he/units_amar_AMR_reg_guidelines.pdf

Keep researching this market
View the Israel resource hub →
Compare regulatory data across all countries →
DJ Fang
Need to apply Israel's requirements to a product?
Confirm the current AMAR pathway, evidence, and local-role details for the actual device before filing.
Pricing